ACM
OGN icon

Advent Capital Management’s Organon & Co OGN Stock Holding History

Advent Capital Management’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-200,000
Closed -$2.98M – 243
2025
Q1 		$2.98M Hold
200,000
– – 0.07% 151
2024
Q4 		$2.98M Buy
200,000
+75,000
+60% +$1.22M 0.07% 131
2024
Q3 		$2.39M Hold
125,000
– – 0.06% 145
2024
Q2 		$2.59M Hold
125,000
– – 0.06% 131
2024
Q1 		$2.35M Buy
+125,000
New +$2.15M 0.06% 132

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Advent Capital Management's OGN Position: Q2 2025 in Review

Advent Capital Management sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 200,000 shares — an estimated $2.98M sold.

Advent Capital Management first reported a position in OGN in Q1 2024 and held it in 5 quarters. The position peaked at $2.98M in Q4 2024. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

  • Advent Capital Management reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
  • Advent Capital Management sold 200,000 Organon & Co shares in Q2 2025, an estimated $2.98M.
  • Advent Capital Management first reported a position in Organon & Co in Q1 2024 and held it in 5 quarters.
  • Advent Capital Management's Organon & Co position peaked at $2.98M in Q4 2024.
  • 695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Advent Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.